This is a Validated Antibody Database (VAD) review about human c-Met, based on 126 published articles (read how Labome selects the articles), using c-Met antibody in all methods. It is aimed to help Labome visitors find the most suited c-Met antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
c-Met synonym: AUTS9; DFNB97; HGFR; RCCP2; c-Met

Knockout validation
Invitrogen
mouse monoclonal (3D4)
  • western blot knockout validation; mouse; fig s1
  • ELISA; mouse
In order to report that MET is required for neutrophil chemoattraction and cytotoxicity in response to its ligand hepatocyte growth factor, Invitrogen c-Met antibody (Invitrogen, 3D4) was used in western blot knockout validation on mouse samples (fig s1) and in ELISA on mouse samples . Nature (2015) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot knockout validation; human; loading ...; fig 1e
Cell Signaling Technology c-Met antibody (Cell Signaling, 4560) was used in western blot knockout validation on human samples (fig 1e). J Exp Med (2019) ncbi
Abcam
domestic rabbit monoclonal (EP1454Y)
  • western blot; human; 1:1000; loading ...; fig 2m, 2n, s3c, s3d
Abcam c-Met antibody (Abcam, ab51067) was used in western blot on human samples at 1:1000 (fig 2m, 2n, s3c, s3d). Cell Death Dis (2022) ncbi
domestic rabbit monoclonal (EP1454Y)
  • immunocytochemistry; mouse; 1:50; loading ...; fig 1c
  • western blot; mouse; 1:100; loading ...; fig 3c
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 6d
Abcam c-Met antibody (Abcam, EP1454Y) was used in immunocytochemistry on mouse samples at 1:50 (fig 1c), in western blot on mouse samples at 1:100 (fig 3c) and in immunohistochemistry - paraffin section on human samples at 1:50 (fig 6d). J Neuroinflammation (2022) ncbi
domestic rabbit monoclonal (EP1454Y)
  • western blot; human; loading ...; fig 8a
Abcam c-Met antibody (Abcam, ab51067) was used in western blot on human samples (fig 8a). Front Cell Dev Biol (2021) ncbi
domestic rabbit monoclonal (EP1454Y)
  • western blot; human; 1:1000; loading ...; fig 5a
Abcam c-Met antibody (Abcam, ab51067) was used in western blot on human samples at 1:1000 (fig 5a). Cancer Cell Int (2021) ncbi
domestic rabbit monoclonal (EP1454Y)
  • western blot; human; loading ...; fig 4d
Abcam c-Met antibody (Abcam, ab51067) was used in western blot on human samples (fig 4d). Cell Death Dis (2020) ncbi
domestic rabbit monoclonal (EP2367Y)
  • western blot; human; loading ...
Abcam c-Met antibody (Abcam, ab68141) was used in western blot on human samples . Cell Death Dis (2020) ncbi
domestic rabbit monoclonal (EP1454Y)
  • proximity ligation assay; human; 1:500; loading ...; fig 3l
Abcam c-Met antibody (Abcam, ab51067) was used in proximity ligation assay on human samples at 1:500 (fig 3l). elife (2020) ncbi
domestic rabbit monoclonal (EP1454Y)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2
Abcam c-Met antibody (Abcam, ab51067) was used in immunohistochemistry - paraffin section on human samples (fig 2). Breast Cancer Res (2020) ncbi
domestic rabbit monoclonal (EP1454Y)
  • western blot; human; loading ...; fig 3c
  • western blot; rat; loading ...; fig 3f
Abcam c-Met antibody (Abcam, AB51067) was used in western blot on human samples (fig 3c) and in western blot on rat samples (fig 3f). Oncogene (2017) ncbi
domestic rabbit monoclonal (EP1454Y)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig st1
Abcam c-Met antibody (Abcam, ab51067) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig st1). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:250; loading ...; fig s7f
In order to demonstrate that Musashi is crucial for pancreatic cancer progression, Abcam c-Met antibody (Abcam, ab5662) was used in immunohistochemistry - paraffin section on mouse samples at 1:250 (fig s7f). Nature (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:4000; fig s2
Abcam c-Met antibody (Abcam, ab5662) was used in immunohistochemistry - paraffin section on mouse samples at 1:4000 (fig s2). Springerplus (2016) ncbi
domestic rabbit monoclonal (EP1454Y)
  • immunohistochemistry - paraffin section; human; fig 8
Abcam c-Met antibody (Abcam, ab51067) was used in immunohistochemistry - paraffin section on human samples (fig 8). Sci Rep (2015) ncbi
domestic rabbit monoclonal (EP1454Y)
  • immunohistochemistry; human
Abcam c-Met antibody (Abcam, ab51067) was used in immunohistochemistry on human samples . J Nucl Med (2014) ncbi
domestic rabbit monoclonal (EP1454Y)
  • western blot; human
Abcam c-Met antibody (Abcam, ab51067) was used in western blot on human samples . Evid Based Complement Alternat Med (2013) ncbi
domestic rabbit monoclonal (EP1454Y)
  • flow cytometry; rat; 1:200
  • immunocytochemistry; rat; 1:200
In order to evaluate the isolation and culture of adult salivary gland-derived stem/progenitor cells, Abcam c-Met antibody (Abcam, ab51067) was used in flow cytometry on rat samples at 1:200 and in immunocytochemistry on rat samples at 1:200. J Tissue Eng Regen Med (2014) ncbi
Invitrogen
mouse monoclonal (3D4)
  • western blot; mouse; loading ...
Invitrogen c-Met antibody (Life Technology, 3D4 #37-0100) was used in western blot on mouse samples . elife (2020) ncbi
domestic rabbit recombinant (22H22L13)
  • western blot; human; loading ...; fig 2b
Invitrogen c-Met antibody (ThermoFisher, 700261) was used in western blot on human samples (fig 2b). Autophagy (2019) ncbi
mouse monoclonal (3D4)
  • western blot; human; 1:1000; loading ...; fig 4a
Invitrogen c-Met antibody (Invitrogen, 3D4) was used in western blot on human samples at 1:1000 (fig 4a). Br J Cancer (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 4d
  • western blot; human; loading ...; fig 4a
In order to find that upregulation of HGF/MET signaling is associated with vemurafenib resistance, Invitrogen c-Met antibody (Invitrogen, 44-882G) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 4d) and in western blot on human samples (fig 4a). Mol Cancer Ther (2016) ncbi
mouse monoclonal (3D4)
  • immunohistochemistry - paraffin section; mouse; fig 5
  • western blot; mouse; fig 4
In order to analyze promotion of development of distinct sarcoma subtypes in hepatocyte growth factor-mediated satellite cells niche disruption, Invitrogen c-Met antibody (Invitrogen, 18-7366) was used in immunohistochemistry - paraffin section on mouse samples (fig 5) and in western blot on mouse samples (fig 4). elife (2016) ncbi
mouse monoclonal (3D4)
  • immunocytochemistry; human; tbl 2
In order to elucidate a unique c-MET-based CTC detection platform, Invitrogen c-Met antibody (Invitrogen, 3D4) was used in immunocytochemistry on human samples (tbl 2). Mol Cancer Res (2016) ncbi
domestic rabbit polyclonal
  • other; human; 1:800; fig s3
  • immunohistochemistry - paraffin section; human; 1:200; fig s4
  • immunocytochemistry; human; 1:1000; fig s2
  • western blot; human; 1:1000; fig s1
In order to learn the poor prognosis marker of patients with oral and oropharyngeal squamous cell carcinoma due to the absence or abundance of MET immunoreactivity, Invitrogen c-Met antibody (Invitrogen, 71-8000) was used in other on human samples at 1:800 (fig s3), in immunohistochemistry - paraffin section on human samples at 1:200 (fig s4), in immunocytochemistry on human samples at 1:1000 (fig s2) and in western blot on human samples at 1:1000 (fig s1). Oncotarget (2016) ncbi
mouse monoclonal (3D4)
  • western blot; human; 1:1000; loading ...; fig st3
In order to study the DNA damage response in senescent epithelial cells, Invitrogen c-Met antibody (Invitrogen, 37-0100) was used in western blot on human samples at 1:1000 (fig st3). Nat Commun (2016) ncbi
mouse monoclonal (3D4)
  • western blot; human; fig s1
In order to characterize enhancement of tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b by H19 non coding RNA-derived miR-675, Invitrogen c-Met antibody (Invitrogen, 37-0100) was used in western blot on human samples (fig s1). Oncotarget (2015) ncbi
domestic rabbit polyclonal
In order to examine the contribution of metastasis-initiating cells to prostate cancer, Invitrogen c-Met antibody (Invitrogen, 44888G) was used . Prostate (2015) ncbi
mouse monoclonal (3D4)
  • western blot knockout validation; mouse; fig s1
  • ELISA; mouse
In order to report that MET is required for neutrophil chemoattraction and cytotoxicity in response to its ligand hepatocyte growth factor, Invitrogen c-Met antibody (Invitrogen, 3D4) was used in western blot knockout validation on mouse samples (fig s1) and in ELISA on mouse samples . Nature (2015) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; human; 1:100
In order to examine the contribution of cerebrospinal fluid during embryonic development, Invitrogen c-Met antibody (Invitrogen, 44888G) was used in immunohistochemistry on human samples at 1:100. Dev Neurobiol (2016) ncbi
mouse monoclonal (3D4)
  • immunohistochemistry - paraffin section; human; 1:200
Invitrogen c-Met antibody (Zymed, 3D4) was used in immunohistochemistry - paraffin section on human samples at 1:200. Clin Epigenetics (2015) ncbi
domestic rabbit polyclonal
In order to assess the contribution of c-Met signaling to dissemination of medulloblastoma, Invitrogen c-Met antibody (Life Technologies, 44888) was used . Springerplus (2015) ncbi
mouse monoclonal (3D4)
  • western blot; human; fig 2
In order to discuss the limitations of c-Kit/PDGFR-targeted therapies for treatment of gastrointestinal stromal tumors, Invitrogen c-Met antibody (Zymed, 3D4) was used in western blot on human samples (fig 2). Oncotarget (2015) ncbi
domestic rabbit polyclonal
In order to suggest that HGF and EGFR signaling mediate ovarian cancer ascites-mediated migration of human peritoneal mesothelial cells, Invitrogen c-Met antibody (Life Technologies ., 71-8000) was used . Int J Cancer (2015) ncbi
domestic rabbit polyclonal
In order to suggest that HGF and EGFR signaling mediate ovarian cancer ascites-mediated migration of human peritoneal mesothelial cells, Invitrogen c-Met antibody (Life Technologies ., 44-888G) was used . Int J Cancer (2015) ncbi
domestic rabbit polyclonal
In order to assess if PC1 and PC2 facilitate cancer aggressiveness, Invitrogen c-Met antibody (Invitrogen, 44888G) was used . Int J Cancer (2015) ncbi
mouse monoclonal (3D4)
  • immunocytochemistry; human; 1:100
Invitrogen c-Met antibody (Life Technologies, 3D4) was used in immunocytochemistry on human samples at 1:100. Mol Endocrinol (2014) ncbi
mouse monoclonal (3D4)
  • immunohistochemistry - frozen section; human; 1:50; fig 4
  • western blot; human; 1:250; fig 2
In order to investigate the role of c-Met in brain metastasis and test its potential as a preventive and/or therapeutic target in this disease, Invitrogen c-Met antibody (Invitrogen, 37-0100) was used in immunohistochemistry - frozen section on human samples at 1:50 (fig 4) and in western blot on human samples at 1:250 (fig 2). Clin Exp Metastasis (2013) ncbi
mouse monoclonal (3D4)
  • immunohistochemistry - paraffin section; human; 4 ug/ml; fig 3
In order to develop and use a co-culture system to systematically assay the influence of 23 stromal cell types on the innate resistance of 45 cancer cell lines to 35 anticancer drugs, Invitrogen c-Met antibody (Invitrogen, 187366) was used in immunohistochemistry - paraffin section on human samples at 4 ug/ml (fig 3). Nature (2012) ncbi
mouse monoclonal (3D4)
  • immunohistochemistry; human; 1:100; fig 3
In order to assess expression and prognostic role of the receptor tyrosine kinase MET, phosphorylated MET, and the ligand hepatocyte growth factor in patients with lung cancer, Invitrogen c-Met antibody (Zymed, 18-7366) was used in immunohistochemistry on human samples at 1:100 (fig 3). J Environ Pathol Toxicol Oncol (2011) ncbi
mouse monoclonal (3D4)
  • immunohistochemistry - paraffin section; human; 1:50
In order to identify diagnostic and prognostic markers for glioblastoma, Invitrogen c-Met antibody (Invitrogen, 370100) was used in immunohistochemistry - paraffin section on human samples at 1:50. Int J Oncol (2012) ncbi
mouse monoclonal (3D4)
  • western blot; human; fig 3
In order to study MET receptor tyrosine kinase as a potential novel therapeutic target for head and neck squamous cell carcinoma, Invitrogen c-Met antibody (Invitrogen, 3D4) was used in western blot on human samples (fig 3). Cancer Res (2009) ncbi
mouse monoclonal (3D4)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 2a
In order to test if c-Met expression is associated with overall survival and tumor invasiveness in patients with glioblastomas, Invitrogen c-Met antibody (Zymed, 3D4) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 2a). Cancer (2009) ncbi
Novus Biologicals
mouse monoclonal (1G7NB)
  • immunohistochemistry - frozen section; human; loading ...; fig 4a, 5
Novus Biologicals c-Met antibody (Novus, NBP2-44306PE) was used in immunohistochemistry - frozen section on human samples (fig 4a, 5). Sci Rep (2022) ncbi
Sino Biological
domestic rabbit monoclonal (271)
  • FACS; human
  • flow cytometry; human; loading ...; fig 2c
  • flow cytometry; domestic rabbit
Sino Biological c-Met antibody (Sino Biological, 10692-R271-A) was used in FACS on human samples , in flow cytometry on human samples (fig 2c) and in flow cytometry on domestic rabbit samples . Nat Commun (2020) ncbi
mouse monoclonal (1A4G4H7)
  • ELISA; human
  • western blot; human; loading ...; fig 6a
  • ELISA; mouse
Sino Biological c-Met antibody (Sino Biological Inc., 10692-MM02) was used in ELISA on human samples , in western blot on human samples (fig 6a) and in ELISA on mouse samples . Oncotarget (2015) ncbi
Santa Cruz Biotechnology
mouse monoclonal (F-5)
  • western blot; human; loading ...; fig 4a
Santa Cruz Biotechnology c-Met antibody (Santa, sc-377548) was used in western blot on human samples (fig 4a). Autophagy (2019) ncbi
mouse monoclonal
  • western blot; human; 1:1000; loading ...; fig 3c
Santa Cruz Biotechnology c-Met antibody (SantaCruz, sc-514148) was used in western blot on human samples at 1:1000 (fig 3c). Biosci Rep (2017) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D26)
  • western blot; human; 1:1000; loading ...; fig 2m, 2n, s3c, s3d
Cell Signaling Technology c-Met antibody (Cell Signaling, 3077) was used in western blot on human samples at 1:1000 (fig 2m, 2n, s3c, s3d). Cell Death Dis (2022) ncbi
domestic rabbit monoclonal (D26)
  • western blot; human; loading ...; fig s3g
Cell Signaling Technology c-Met antibody (CST, 3077) was used in western blot on human samples (fig s3g). J Immunother Cancer (2022) ncbi
mouse monoclonal (25H2)
  • western blot; human; loading ...; fig s3g
Cell Signaling Technology c-Met antibody (CST, 3127) was used in western blot on human samples (fig s3g). J Immunother Cancer (2022) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; human; fig 7c
Cell Signaling Technology c-Met antibody (Cell Signaling, 8198) was used in western blot on human samples (fig 7c). Cell Death Dis (2022) ncbi
domestic rabbit monoclonal (D26)
  • western blot; human; fig 7c
Cell Signaling Technology c-Met antibody (Cell Signaling, 3077) was used in western blot on human samples (fig 7c). Cell Death Dis (2022) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology c-Met antibody (Cell Signaling Technology, 8198) was used in western blot on human samples at 1:1000 (fig 3a). J Exp Clin Cancer Res (2021) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; human; loading ...; fig 5b
Cell Signaling Technology c-Met antibody (Cell Signaling, 8198) was used in western blot on human samples (fig 5b). Cancers (Basel) (2021) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; human; loading ...; fig 2d
Cell Signaling Technology c-Met antibody (CST, 8198) was used in western blot on human samples (fig 2d). iScience (2021) ncbi
domestic rabbit monoclonal (D1C2)
  • immunohistochemistry; mouse; 1:250; loading ...; fig 5d
Cell Signaling Technology c-Met antibody (CST, C8198) was used in immunohistochemistry on mouse samples at 1:250 (fig 5d). Genes Dev (2021) ncbi
domestic rabbit monoclonal (D26)
  • western blot; human; loading ...
Cell Signaling Technology c-Met antibody (CST (Cell Signaling Technology), 3077) was used in western blot on human samples . Front Cell Dev Biol (2021) ncbi
mouse monoclonal (25H2)
  • western blot; human; 1:1000; loading ...; fig s9c
Cell Signaling Technology c-Met antibody (Cell Signaling Technology, 3127s) was used in western blot on human samples at 1:1000 (fig s9c). Nat Commun (2021) ncbi
mouse monoclonal (25H2)
  • western blot; human; loading ...; fig 1d
Cell Signaling Technology c-Met antibody (Cell Signaling, 3127) was used in western blot on human samples (fig 1d). Oncogenesis (2021) ncbi
domestic rabbit monoclonal (D26)
  • western blot; human; loading ...; fig 1e
Cell Signaling Technology c-Met antibody (Cell Signaling, 3077) was used in western blot on human samples (fig 1e). Oncogenesis (2021) ncbi
domestic rabbit monoclonal (D26)
  • western blot; human; 1:2000; loading ...; fig 3a
Cell Signaling Technology c-Met antibody (Cell signaling Technology, 3077) was used in western blot on human samples at 1:2000 (fig 3a). BMC Cancer (2021) ncbi
domestic rabbit polyclonal
  • western blot; dogs; loading ...; fig 5d
Cell Signaling Technology c-Met antibody (Cell Signaling, 3121) was used in western blot on dogs samples (fig 5d). Life Sci Alliance (2021) ncbi
mouse monoclonal (25H2)
  • western blot; human; loading ...; fig s7b
  • western blot; dogs; loading ...; fig s1d
Cell Signaling Technology c-Met antibody (Cell Signaling, 3127) was used in western blot on human samples (fig s7b) and in western blot on dogs samples (fig s1d). Life Sci Alliance (2021) ncbi
domestic rabbit monoclonal (D26)
  • western blot; dogs; loading ...; fig s1d
  • western blot; human; loading ...; fig s7b
Cell Signaling Technology c-Met antibody (Cell Signaling, 3077) was used in western blot on dogs samples (fig s1d) and in western blot on human samples (fig s7b). Life Sci Alliance (2021) ncbi
domestic rabbit monoclonal (D1C2)
  • immunocytochemistry; dogs; loading ...; fig s7a
Cell Signaling Technology c-Met antibody (Cell Signaling, 8198) was used in immunocytochemistry on dogs samples (fig s7a). Life Sci Alliance (2021) ncbi
domestic rabbit monoclonal (D26)
  • western blot; mouse; 1:1000; loading ...; fig 4c, 6e
  • western blot; human; 1:1000; loading ...; fig 4d
Cell Signaling Technology c-Met antibody (Cell Signaling, 3077) was used in western blot on mouse samples at 1:1000 (fig 4c, 6e) and in western blot on human samples at 1:1000 (fig 4d). Mol Cell Biol (2021) ncbi
mouse monoclonal (25H2)
  • western blot; human; 1:500; loading ...; fig 4d
  • western blot; mouse; 1:500; loading ...; fig 4c, 5b
Cell Signaling Technology c-Met antibody (Cell Signaling, 3127) was used in western blot on human samples at 1:500 (fig 4d) and in western blot on mouse samples at 1:500 (fig 4c, 5b). Mol Cell Biol (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 4a
Cell Signaling Technology c-Met antibody (Cell Signaling, 3126) was used in western blot on mouse samples at 1:1000 (fig 4a). Cancer Sci (2021) ncbi
mouse monoclonal (25H2)
  • western blot; mouse; 1:1000; loading ...; fig 4a
Cell Signaling Technology c-Met antibody (Cell Signaling, 3127) was used in western blot on mouse samples at 1:1000 (fig 4a). Cancer Sci (2021) ncbi
mouse monoclonal (25H2)
  • western blot; human; 1:500; loading ...; fig 2a, 4c
Cell Signaling Technology c-Met antibody (CST, 3127) was used in western blot on human samples at 1:500 (fig 2a, 4c). Nat Commun (2020) ncbi
domestic rabbit monoclonal (D26)
  • western blot; human; 1:1000; loading ...; fig 4c
Cell Signaling Technology c-Met antibody (CST, 3077) was used in western blot on human samples at 1:1000 (fig 4c). Nat Commun (2020) ncbi
mouse monoclonal (L41G3)
  • western blot; human; 1:1000; loading ...; fig 1f
Cell Signaling Technology c-Met antibody (Cell Signaling Technology, #3148S) was used in western blot on human samples at 1:1000 (fig 1f). elife (2020) ncbi
domestic rabbit monoclonal (D26)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig s2c
  • immunocytochemistry; human; 1:200; loading ...; fig 2e
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology c-Met antibody (Cell signaling, 3077) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s2c), in immunocytochemistry on human samples at 1:200 (fig 2e) and in western blot on human samples at 1:1000 (fig 3a). Nat Commun (2020) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; human; 1:1000; loading ...; fig s4
Cell Signaling Technology c-Met antibody (Cell signaling, 8198) was used in western blot on human samples at 1:1000 (fig s4). Nat Commun (2020) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; mouse; 1:1000; loading ...; fig s4b
Cell Signaling Technology c-Met antibody (Cell Signaling, 8198) was used in western blot on mouse samples at 1:1000 (fig s4b). Cancer Cell (2020) ncbi
mouse monoclonal (25H2)
  • western blot; mouse; loading ...; fig 7b
Cell Signaling Technology c-Met antibody (CST, 3127) was used in western blot on mouse samples (fig 7b). Am J Pathol (2020) ncbi
domestic rabbit monoclonal (D26)
  • western blot; mouse; loading ...; fig 7b
Cell Signaling Technology c-Met antibody (CST, 3077) was used in western blot on mouse samples (fig 7b). Am J Pathol (2020) ncbi
domestic rabbit monoclonal (D1C2)
  • immunohistochemistry - frozen section; human; loading ...; fig 5c
Cell Signaling Technology c-Met antibody (Cell Signaling Technologies, 8198) was used in immunohistochemistry - frozen section on human samples (fig 5c). Acta Neuropathol Commun (2019) ncbi
domestic rabbit monoclonal (D26)
  • western blot; human; loading ...; fig s4s
Cell Signaling Technology c-Met antibody (Cell Signaling, 3077) was used in western blot on human samples (fig s4s). Cell (2019) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; human; loading ...; fig s4s
Cell Signaling Technology c-Met antibody (Cell Signaling, 8198) was used in western blot on human samples (fig s4s). Cell (2019) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; human; 1:1000; loading ...
Cell Signaling Technology c-Met antibody (Cell Signaling Technology, 8198) was used in western blot on human samples at 1:1000. Nat Commun (2019) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; human; loading ...; fig 3d
Cell Signaling Technology c-Met antibody (CST, 8198) was used in western blot on human samples (fig 3d). Cell Commun Signal (2019) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; human; loading ...; fig 4h
Cell Signaling Technology c-Met antibody (CST, 8198) was used in western blot on human samples (fig 4h). J Exp Clin Cancer Res (2019) ncbi
domestic rabbit monoclonal (D26)
  • western blot; human; 1:1000; loading ...; fig 6d
Cell Signaling Technology c-Met antibody (Cell Signaling, 3077) was used in western blot on human samples at 1:1000 (fig 6d). Cell Metab (2019) ncbi
domestic rabbit polyclonal
  • western blot knockout validation; human; loading ...; fig 1e
Cell Signaling Technology c-Met antibody (Cell Signaling, 4560) was used in western blot knockout validation on human samples (fig 1e). J Exp Med (2019) ncbi
mouse monoclonal (25H2)
  • western blot; human; 1:1000; loading ...; fig 3c
Cell Signaling Technology c-Met antibody (Cell Signalling Technology, 3127) was used in western blot on human samples at 1:1000 (fig 3c). EMBO Mol Med (2019) ncbi
domestic rabbit monoclonal (D26)
  • western blot; human; 1:1000; loading ...; fig 3c
Cell Signaling Technology c-Met antibody (Cell Signalling Technology, 3077) was used in western blot on human samples at 1:1000 (fig 3c). EMBO Mol Med (2019) ncbi
domestic rabbit monoclonal (D1C2)
  • mass cytometry; human; loading ...; fig 3a
Cell Signaling Technology c-Met antibody (Cell Signaling Technologies, 8198) was used in mass cytometry on human samples (fig 3a). Cell (2019) ncbi
domestic rabbit monoclonal (D26)
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology c-Met antibody (Cell Signaling Technology, 3077) was used in western blot on human samples (fig 4a). J Biol Chem (2019) ncbi
domestic rabbit monoclonal (D1C2)
  • immunohistochemistry - paraffin section; human; loading ...; fig 7a
  • immunocytochemistry; human; loading ...; fig 4b
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology c-Met antibody (Cell Signaling, 8198) was used in immunohistochemistry - paraffin section on human samples (fig 7a), in immunocytochemistry on human samples (fig 4b) and in western blot on human samples (fig 4a). Breast Cancer Res (2019) ncbi
domestic rabbit monoclonal (D26)
  • immunohistochemistry; human; loading ...; fig 8a
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology c-Met antibody (Cell Signaling, 3077) was used in immunohistochemistry on human samples (fig 8a) and in western blot on human samples (fig 4a). Autophagy (2019) ncbi
domestic rabbit monoclonal (130H2)
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology c-Met antibody (Cell Signaling, 3133) was used in western blot on human samples (fig 4a). Autophagy (2019) ncbi
domestic rabbit monoclonal (13D11)
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology c-Met antibody (Cell Signaling, 3135) was used in western blot on human samples (fig 4a). Autophagy (2019) ncbi
domestic rabbit monoclonal (D26)
  • immunocytochemistry; human; 1:700; loading ...; fig 5a
  • western blot; human; 1:1000; loading ...; fig 4a
Cell Signaling Technology c-Met antibody (Cell Signaling, D26) was used in immunocytochemistry on human samples at 1:700 (fig 5a) and in western blot on human samples at 1:1000 (fig 4a). Br J Cancer (2019) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology c-Met antibody (Cell Signaling, 8198) was used in western blot on human samples at 1:1000 (fig 3a). Oncogene (2019) ncbi
domestic rabbit monoclonal (D26)
  • immunocytochemistry; human; 1:100; loading ...; fig 6d
  • western blot; human; loading ...; fig 6e
Cell Signaling Technology c-Met antibody (Cell Signaling, 3077) was used in immunocytochemistry on human samples at 1:100 (fig 6d) and in western blot on human samples (fig 6e). Oncogene (2019) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; mouse; loading ...; fig s4d
Cell Signaling Technology c-Met antibody (Cell Signaling, 8198) was used in western blot on mouse samples (fig s4d). Cell (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology c-Met antibody (Cell Signaling Technology, 4560) was used in western blot on human samples (fig 2c). Infect Immun (2019) ncbi
domestic rabbit monoclonal (D1C2)
  • immunohistochemistry - paraffin section; human; 1:1000; fig 3d
  • western blot; human; 1:1000; loading ...; fig 3c
Cell Signaling Technology c-Met antibody (Cell Signaling Technology, D1C2) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 3d) and in western blot on human samples at 1:1000 (fig 3c). Nucleic Acids Res (2018) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology c-Met antibody (Cell Signaling Technology, 8198) was used in western blot on human samples (fig 1b). Proc Natl Acad Sci U S A (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s10f
Cell Signaling Technology c-Met antibody (Cell Signaling, 3126) was used in western blot on human samples (fig s10f). Nat Med (2018) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; human; loading ...; fig s10f
Cell Signaling Technology c-Met antibody (Cell Signaling, 8198) was used in western blot on human samples (fig s10f). Nat Med (2018) ncbi
mouse monoclonal (25H2)
  • other; human; loading ...; fig 4c
Cell Signaling Technology c-Met antibody (Cell Signaling, 3127) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
domestic rabbit monoclonal (3D7)
  • other; human; loading ...; fig 4c
Cell Signaling Technology c-Met antibody (Cell Signaling, 3129) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; human; 1:1000; loading ...
Cell Signaling Technology c-Met antibody (Cell Signaling, 8198) was used in western blot on human samples at 1:1000. elife (2017) ncbi
mouse monoclonal (25H2)
  • immunohistochemistry; rhesus macaque; 1:400; loading ...; fig 4a
  • immunohistochemistry; mouse; 1:400; loading ...; fig 1a
In order to characterize MET-positive subpopulations of mouse brainstem vagal neurons, Cell Signaling Technology c-Met antibody (Cell Signaling, 3127) was used in immunohistochemistry on rhesus macaque samples at 1:400 (fig 4a) and in immunohistochemistry on mouse samples at 1:400 (fig 1a). J Comp Neurol (2017) ncbi
domestic rabbit monoclonal (130H2)
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology c-Met antibody (Cell Signaling, 3133) was used in western blot on human samples (fig 4a). Mol Oncol (2017) ncbi
domestic rabbit monoclonal (D26)
  • western blot; human; loading ...; fig 2
Cell Signaling Technology c-Met antibody (Cell Signaling, 3077) was used in western blot on human samples (fig 2). Mol Oncol (2017) ncbi
domestic rabbit monoclonal (3D7)
  • western blot; human; 1:1000; loading ...; fig s3e
Cell Signaling Technology c-Met antibody (Cell Signaling Technology, 3129) was used in western blot on human samples at 1:1000 (fig s3e). Nat Commun (2017) ncbi
mouse monoclonal (L41G3)
  • western blot; human; 1:1000; loading ...; fig s3e
Cell Signaling Technology c-Met antibody (Cell Signaling Technology, 3148) was used in western blot on human samples at 1:1000 (fig s3e). Nat Commun (2017) ncbi
domestic rabbit monoclonal (D26)
  • western blot; human; fig s5d
In order to study the effect of GNAQ mutations and GNA11/MAPK pathway activation in uveal melanoma, Cell Signaling Technology c-Met antibody (Cell Signaling, 3077) was used in western blot on human samples (fig s5d). Cancer Cell (2017) ncbi
mouse monoclonal (25H2)
  • western blot; human; fig s5d
In order to study the effect of GNAQ mutations and GNA11/MAPK pathway activation in uveal melanoma, Cell Signaling Technology c-Met antibody (Cell Signaling, 3127) was used in western blot on human samples (fig s5d). Cancer Cell (2017) ncbi
domestic rabbit monoclonal (D26)
  • western blot; mouse; loading ...; fig 3b
Cell Signaling Technology c-Met antibody (Cell Signaling Technology, 3077) was used in western blot on mouse samples (fig 3b). Nature (2017) ncbi
mouse monoclonal (25H2)
  • reverse phase protein lysate microarray; human; loading ...; fig st6
In order to characterize the molecular identity of uterine carcinosarcomas., Cell Signaling Technology c-Met antibody (CST, 3127) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
domestic rabbit monoclonal (3D7)
  • reverse phase protein lysate microarray; human; loading ...; fig st6
In order to characterize the molecular identity of uterine carcinosarcomas., Cell Signaling Technology c-Met antibody (CST, 3129) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
domestic rabbit monoclonal (130H2)
  • immunohistochemistry - paraffin section; human; 1:25; loading ...; fig st13
In order to outline the protocols for antibodies used for immunohistochemical studies, Cell Signaling Technology c-Met antibody (Cell Signaling Technology, 3133) was used in immunohistochemistry - paraffin section on human samples at 1:25 (fig st13). J Toxicol Pathol (2017) ncbi
domestic rabbit monoclonal (D26)
  • western blot; human; loading ...; fig 6c
In order to demonstrate that sorting nexin 1 and 2 are cleaved by initiator caspases during apoptosis, Cell Signaling Technology c-Met antibody (Cell Signaling, 3077) was used in western blot on human samples (fig 6c). Cell Death Discov (2017) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; human; loading ...; fig s2c
Cell Signaling Technology c-Met antibody (CST, 8198) was used in western blot on human samples (fig s2c). Sci Rep (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s2a
Cell Signaling Technology c-Met antibody (CST, 3126) was used in western blot on human samples (fig s2a). Sci Rep (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s2c
Cell Signaling Technology c-Met antibody (CST, 4560) was used in western blot on human samples (fig s2c). Sci Rep (2017) ncbi
domestic rabbit monoclonal (3D7)
  • reverse phase protein lysate microarray; human; loading ...; fig 3a
In order to describe the features of 228 primary cervical cancers, Cell Signaling Technology c-Met antibody (Cell Signaling, 3129) was used in reverse phase protein lysate microarray on human samples (fig 3a). Nature (2017) ncbi
domestic rabbit monoclonal (3D7)
  • western blot; human; loading ...
In order to analyze the context specificity of signaling networks within a causal conceptual framework using reverse-phase protein array time-course assays and network analysis approaches, Cell Signaling Technology c-Met antibody (Cell Signaling Technology, 3129) was used in western blot on human samples . Cell Syst (2017) ncbi
domestic rabbit monoclonal (D26)
  • western blot; human; loading ...; fig 6c
In order to assess the effects of LY3009120, a panRAF and RAF dimer inhibitor, in human models of colorectal cancer, Cell Signaling Technology c-Met antibody (Cell Signaling, 3077) was used in western blot on human samples (fig 6c). Oncotarget (2017) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; human; loading ...; fig 6c
In order to assess the effects of LY3009120, a panRAF and RAF dimer inhibitor, in human models of colorectal cancer, Cell Signaling Technology c-Met antibody (Cell Signaling, 8198) was used in western blot on human samples (fig 6c). Oncotarget (2017) ncbi
mouse monoclonal (25H2)
  • western blot; human; 1:500; loading ...; fig 3a
In order to examine the role of Breast Cancer Associated gene 2 in EGFR endocytosis and down-regulation and to determine its links with breast cancer outcome, Cell Signaling Technology c-Met antibody (Cell signaling, 3127) was used in western blot on human samples at 1:500 (fig 3a). J Cancer (2016) ncbi
mouse monoclonal (L41G3)
  • western blot; human; fig 5c
In order to elucidate how JNJ-61186372 attenuates therapeutic resistance in patients with epidermal growth factor receptor mutations, Cell Signaling Technology c-Met antibody (Cell signaling, 3148) was used in western blot on human samples (fig 5c). MAbs (2017) ncbi
domestic rabbit monoclonal (D26)
  • western blot; human; fig 5d
In order to elucidate how JNJ-61186372 attenuates therapeutic resistance in patients with epidermal growth factor receptor mutations, Cell Signaling Technology c-Met antibody (Cell signaling, 3077) was used in western blot on human samples (fig 5d). MAbs (2017) ncbi
mouse monoclonal (25H2)
  • immunoprecipitation; mouse; loading ...; fig 1c
  • western blot; mouse; 1:1000; loading ...; fig 1c
In order to investigate the phenotypic changes caused by Met expression levels in metastatic melanoma., Cell Signaling Technology c-Met antibody (Cell Signaling, 3127) was used in immunoprecipitation on mouse samples (fig 1c) and in western blot on mouse samples at 1:1000 (fig 1c). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D26)
  • western blot; mouse; 1:1000; loading ...; fig 1c
In order to investigate the phenotypic changes caused by Met expression levels in metastatic melanoma., Cell Signaling Technology c-Met antibody (Cell Signaling, 3077) was used in western blot on mouse samples at 1:1000 (fig 1c). Oncotarget (2016) ncbi
mouse monoclonal (25H2)
  • western blot; human; loading ...; fig 2c
In order to study how CUB domain-containing protein1 contributes to metastasis and drug resistance, Cell Signaling Technology c-Met antibody (Cell Signaling, 3127) was used in western blot on human samples (fig 2c). Breast Cancer Res (2016) ncbi
domestic rabbit monoclonal (D26)
  • western blot; human; fig 5b
In order to develop a patient-derived xenograft platform and use it to identify genes that contribute the cancer resistance of melanoma patients treated with BRAF inhibitors, Cell Signaling Technology c-Met antibody (CST, 3077) was used in western blot on human samples (fig 5b). Cell Rep (2016) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; human; loading ...; fig 4e
Cell Signaling Technology c-Met antibody (Cell Signaling, 8198) was used in western blot on human samples (fig 4e). EBioMedicine (2016) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; human; 1:1000; loading ...; fig 4b
Cell Signaling Technology c-Met antibody (Cell Signaling Technology, 8198) was used in western blot on human samples at 1:1000 (fig 4b). J Clin Invest (2016) ncbi
domestic rabbit monoclonal (D26)
  • western blot; human; 1:1000; loading ...; fig 4b
Cell Signaling Technology c-Met antibody (Cell Signaling Technology, 3077) was used in western blot on human samples at 1:1000 (fig 4b). J Clin Invest (2016) ncbi
mouse monoclonal (25H2)
  • western blot; mouse; loading ...; fig s7l
In order to research the roles of HSF1 and mTORC1 in proteotoxic stress and cell growth, Cell Signaling Technology c-Met antibody (Cell Signaling, 3127) was used in western blot on mouse samples (fig s7l). Nat Cell Biol (2016) ncbi
domestic rabbit monoclonal (D26)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 8n
In order to research the roles of HSF1 and mTORC1 in proteotoxic stress and cell growth, Cell Signaling Technology c-Met antibody (Cell Signaling, 4033) was used in immunohistochemistry - frozen section on mouse samples (fig 8n). Nat Cell Biol (2016) ncbi
domestic rabbit monoclonal (D1C2)
  • immunohistochemistry - paraffin section; human; loading ...; fig s1i
Cell Signaling Technology c-Met antibody (Cell Signaling, D1C2) was used in immunohistochemistry - paraffin section on human samples (fig s1i). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit monoclonal (D26)
  • immunohistochemistry - paraffin section; human; loading ...; fig s1j
Cell Signaling Technology c-Met antibody (Cell Signaling, D26) was used in immunohistochemistry - paraffin section on human samples (fig s1j). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; fig 5
  • western blot; mouse; fig 4
In order to analyze promotion of development of distinct sarcoma subtypes in hepatocyte growth factor-mediated satellite cells niche disruption, Cell Signaling Technology c-Met antibody (Cell signaling, 3126) was used in immunohistochemistry - paraffin section on mouse samples (fig 5) and in western blot on mouse samples (fig 4). elife (2016) ncbi
domestic rabbit monoclonal (D1C2)
  • other; human; 1:400; fig s3
  • immunohistochemistry - paraffin section; human; 1:100; fig s4
  • immunocytochemistry; human; 1:1000; fig s2
  • western blot; human; 1:1000; fig s1
In order to learn the poor prognosis marker of patients with oral and oropharyngeal squamous cell carcinoma due to the absence or abundance of MET immunoreactivity, Cell Signaling Technology c-Met antibody (Cell Signaling Technology, 8198) was used in other on human samples at 1:400 (fig s3), in immunohistochemistry - paraffin section on human samples at 1:100 (fig s4), in immunocytochemistry on human samples at 1:1000 (fig s2) and in western blot on human samples at 1:1000 (fig s1). Oncotarget (2016) ncbi
mouse monoclonal (L41G3)
  • western blot; human; fig 1
In order to learn how oncogene addiction can be broken in tumors with MET amplification by the Anti-c-Met monoclonal antibody ABT-700, Cell Signaling Technology c-Met antibody (Cell Signaling, 3148) was used in western blot on human samples (fig 1). BMC Cancer (2016) ncbi
domestic rabbit monoclonal (D26)
  • immunohistochemistry - paraffin section; human; fig 3
  • western blot; human; fig 1
In order to learn how oncogene addiction can be broken in tumors with MET amplification by the Anti-c-Met monoclonal antibody ABT-700, Cell Signaling Technology c-Met antibody (Cell Signaling, 3077) was used in immunohistochemistry - paraffin section on human samples (fig 3) and in western blot on human samples (fig 1). BMC Cancer (2016) ncbi
  • western blot; human; fig 4
Cell Signaling Technology c-Met antibody (Cell signaling, 8218) was used in western blot on human samples (fig 4). Oncogene (2016) ncbi
domestic rabbit monoclonal (D1C2)
  • immunohistochemistry; human; fig 2
Cell Signaling Technology c-Met antibody (Cell signaling, 8198) was used in immunohistochemistry on human samples (fig 2). Oncogene (2016) ncbi
domestic rabbit monoclonal (D26)
  • western blot; human; fig 3
Cell Signaling Technology c-Met antibody (Cell Signaling, 3077S) was used in western blot on human samples (fig 3). PLoS ONE (2016) ncbi
mouse monoclonal (25H2)
  • western blot; human; fig 3
Cell Signaling Technology c-Met antibody (Cell Signaling, 3127) was used in western blot on human samples (fig 3). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (3D7)
  • western blot; human; fig 1
In order to study how ZEB1 drives the epithelial-mesenchymal transition-related resistance to EGFR-tyrosine kinases inhibitors in non-small cell lung cancer, Cell Signaling Technology c-Met antibody (Cell Signaling, 3129) was used in western blot on human samples (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (25H2)
  • western blot; human; fig 1
In order to study how ZEB1 drives the epithelial-mesenchymal transition-related resistance to EGFR-tyrosine kinases inhibitors in non-small cell lung cancer, Cell Signaling Technology c-Met antibody (Cell Signaling, 3127) was used in western blot on human samples (fig 1). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (D26)
  • western blot; human; 1:1000; fig 3
Cell Signaling Technology c-Met antibody (Cell Signaling, 3077) was used in western blot on human samples at 1:1000 (fig 3). Nat Med (2016) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; human; fig 3
Cell Signaling Technology c-Met antibody (Cell Signaling, 8198) was used in western blot on human samples (fig 3). Nat Med (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:50; loading ...; fig 8c
In order to demonstrate that receptor tyrosine kinase-like orphan receptor 1 is a scaffold for cavin-1 and caveolin-1, Cell Signaling Technology c-Met antibody (Cell Signaling, 3126) was used in western blot on human samples at 1:50 (fig 8c). Nat Commun (2016) ncbi
mouse monoclonal (25H2)
  • western blot; human; 1:50; loading ...; fig 2b
In order to demonstrate that receptor tyrosine kinase-like orphan receptor 1 is a scaffold for cavin-1 and caveolin-1, Cell Signaling Technology c-Met antibody (Cell Signaling, 3127) was used in western blot on human samples at 1:50 (fig 2b). Nat Commun (2016) ncbi
domestic rabbit monoclonal (3D7)
  • western blot; mouse; fig st1
Cell Signaling Technology c-Met antibody (Cell Signaling, 3129) was used in western blot on mouse samples (fig st1). Liver Int (2016) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; mouse; fig st1
Cell Signaling Technology c-Met antibody (Cell Signaling, 8198) was used in western blot on mouse samples (fig st1). Liver Int (2016) ncbi
mouse monoclonal (25H2)
  • immunocytochemistry; rat; fig 3
In order to investigate the role of neuron-enriched Na(+)/H(+) exchanger NHE5, Cell Signaling Technology c-Met antibody (Cell Signaling Technology, 3127) was used in immunocytochemistry on rat samples (fig 3). Mol Biol Cell (2016) ncbi
domestic rabbit monoclonal (D26)
In order to characterize distinct binding preferences for constitutive and stress-induced HSP90 isoforms and conformationally restricted mutants in regards to client proteins and small molecule inhibitors, Cell Signaling Technology c-Met antibody (Cell Signaling, 3077) was used . PLoS ONE (2015) ncbi
mouse monoclonal (25H2)
In order to characterize distinct binding preferences for constitutive and stress-induced HSP90 isoforms and conformationally restricted mutants in regards to client proteins and small molecule inhibitors, Cell Signaling Technology c-Met antibody (Cell Signaling, 3127) was used . PLoS ONE (2015) ncbi
domestic rabbit monoclonal (D26)
  • immunohistochemistry - paraffin section; human; 1:200-1:500; fig 4i
In order to elucidate how EGFR mutations contribute to glioblastoma development, Cell Signaling Technology c-Met antibody (Cell Signaling, 3077P) was used in immunohistochemistry - paraffin section on human samples at 1:200-1:500 (fig 4i). Mol Cell (2015) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; human; fig 9a
In order to demonstrate that LRIG1 functions as a growth suppressor in breast cancer cells, Cell Signaling Technology c-Met antibody (Cell Signaling Technology, 8198) was used in western blot on human samples (fig 9a). Oncogene (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 7a
In order to demonstrate that LRIG1 functions as a growth suppressor in breast cancer cells, Cell Signaling Technology c-Met antibody (Cell Signaling Technology, 3121) was used in western blot on human samples (fig 7a). Oncogene (2016) ncbi
domestic rabbit monoclonal (13D11)
  • western blot; human; fig s1
In order to characterize enhancement of tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b by H19 non coding RNA-derived miR-675, Cell Signaling Technology c-Met antibody (Cell signaling, 3135) was used in western blot on human samples (fig s1). Oncotarget (2015) ncbi
mouse monoclonal (25H2)
  • western blot; human; loading ...; fig 3a
In order to report the effect of c-Met inhibition using neuroendocrine tumor cells, Cell Signaling Technology c-Met antibody (Cell Signaling, 3127) was used in western blot on human samples (fig 3a). Neuroendocrinology (2016) ncbi
domestic rabbit monoclonal (D26)
  • western blot; human; loading ...; fig 3a
In order to report the effect of c-Met inhibition using neuroendocrine tumor cells, Cell Signaling Technology c-Met antibody (Cell Signaling, 3077) was used in western blot on human samples (fig 3a). Neuroendocrinology (2016) ncbi
domestic rabbit monoclonal (3D7)
  • western blot; human; loading ...; fig 6a
Cell Signaling Technology c-Met antibody (Cell signaling, 3129) was used in western blot on human samples (fig 6a). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D26)
  • western blot; human; loading ...; fig 1C
In order to study mechanisms that confer resistance to therapeutic interventions in the insulin-like growth factor receptor pathway, Cell Signaling Technology c-Met antibody (CST, 3077) was used in western blot on human samples (fig 1C). Mol Cancer (2015) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; human; 1:1000; fig 2
Cell Signaling Technology c-Met antibody (Cell signaling, 8198) was used in western blot on human samples at 1:1000 (fig 2). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; human; fig 3g
In order to report that MET is required for neutrophil chemoattraction and cytotoxicity in response to its ligand hepatocyte growth factor, Cell Signaling Technology c-Met antibody (Cell Signaling, D1C2) was used in western blot on human samples (fig 3g). Nature (2015) ncbi
domestic rabbit monoclonal (D26)
  • immunohistochemistry - paraffin section; human
  • western blot; human
In order to identify and characterize a novel variant of MET that is expressed in high-grade gliomas, Cell Signaling Technology c-Met antibody (CST, D26) was used in immunohistochemistry - paraffin section on human samples and in western blot on human samples . Acta Neuropathol (2015) ncbi
domestic rabbit monoclonal (D1C2)
  • immunohistochemistry - paraffin section; human
  • western blot; human
In order to identify and characterize a novel variant of MET that is expressed in high-grade gliomas, Cell Signaling Technology c-Met antibody (CST, D1C2) was used in immunohistochemistry - paraffin section on human samples and in western blot on human samples . Acta Neuropathol (2015) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; human; fig 5
Cell Signaling Technology c-Met antibody (Cell Signaling, 8198) was used in western blot on human samples (fig 5). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D26)
  • western blot; human; fig 5
Cell Signaling Technology c-Met antibody (Cell Signaling, 3077) was used in western blot on human samples (fig 5). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; human; fig 5
Cell Signaling Technology c-Met antibody (Cell Signaling, 8198) was used in western blot on human samples (fig 5). Sci Rep (2015) ncbi
domestic rabbit monoclonal (3D7)
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology c-Met antibody (Cell Signaling, 3D7) was used in western blot on human samples (fig 1b). Oncogene (2015) ncbi
mouse monoclonal (25H2)
  • western blot; human; fig 6
Cell Signaling Technology c-Met antibody (Cell Signaling, 3127) was used in western blot on human samples (fig 6). Cell Res (2015) ncbi
mouse monoclonal (11C4)
  • flow cytometry; human; 1:100; fig 1
In order to assess the contribution of c-Met signaling to dissemination of medulloblastoma, Cell Signaling Technology c-Met antibody (Cell signaling, 5631) was used in flow cytometry on human samples at 1:100 (fig 1). Springerplus (2015) ncbi
mouse monoclonal (L41G3)
  • immunocytochemistry; human; fig 5
  • western blot; human; fig 1
In order to assess the contribution of c-Met signaling to dissemination of medulloblastoma, Cell Signaling Technology c-Met antibody (Cell Signaling, 3148) was used in immunocytochemistry on human samples (fig 5) and in western blot on human samples (fig 1). Springerplus (2015) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; human; fig 1
In order to study hepatocyte growth factor signaling and resistance to targeted cancer drugs, Cell Signaling Technology c-Met antibody (Cell Signaling, 8198) was used in western blot on human samples (fig 1). Cell Cycle (2014) ncbi
domestic rabbit monoclonal (D26)
  • western blot; human; fig 1
In order to study hepatocyte growth factor signaling and resistance to targeted cancer drugs, Cell Signaling Technology c-Met antibody (Cell Signaling, 3077) was used in western blot on human samples (fig 1). Cell Cycle (2014) ncbi
domestic rabbit monoclonal (D1C2)
  • western blot; mouse; 1:1000; fig 4
In order to elucidate how polycystin-1 and -2 traffic to cilia, Cell Signaling Technology c-Met antibody (Cell signaling, 8198) was used in western blot on mouse samples at 1:1000 (fig 4). Nat Commun (2014) ncbi
domestic rabbit monoclonal (D1C2)
  • immunohistochemistry; human; 1:300; fig 2
In order to determine the effects of targeting the VEGF and c-met pathways in clear cell renal cell carcinoma models, Cell Signaling Technology c-Met antibody (Cell Signaling, 8198) was used in immunohistochemistry on human samples at 1:300 (fig 2). Mol Cancer Ther (2015) ncbi
domestic rabbit monoclonal (3D7)
  • immunohistochemistry - paraffin section; human
  • immunocytochemistry; human
  • western blot; human
Cell Signaling Technology c-Met antibody (cell signaling, 3129) was used in immunohistochemistry - paraffin section on human samples , in immunocytochemistry on human samples and in western blot on human samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (D1C2)
  • immunocytochemistry; human; 1:50
Cell Signaling Technology c-Met antibody (Cell Signaling, D1C2) was used in immunocytochemistry on human samples at 1:50. Mol Endocrinol (2014) ncbi
domestic rabbit monoclonal (3D7)
  • western blot; human
Cell Signaling Technology c-Met antibody (cell signaling, 3129) was used in western blot on human samples . Biochem Biophys Res Commun (2014) ncbi
domestic rabbit monoclonal (D26)
  • western blot; mouse; fig s3
In order to investigate the role of mTOR and Wnt signaling proteins to c-Met TKI resistance in melanoma cell lines, Cell Signaling Technology c-Met antibody (Cell Signaling Technology, 3077) was used in western blot on mouse samples (fig s3). Cancer Biol Ther (2014) ncbi
mouse monoclonal (25H2)
  • western blot; rat
Cell Signaling Technology c-Met antibody (Cell Signaling Technology, 3127) was used in western blot on rat samples . Int J Mol Med (2014) ncbi
domestic rabbit monoclonal (13D11)
  • western blot; rat
Cell Signaling Technology c-Met antibody (Cell Signaling Technology, 3135) was used in western blot on rat samples . Int J Mol Med (2014) ncbi
domestic rabbit monoclonal (3D7)
  • western blot; human
Cell Signaling Technology c-Met antibody (Cell Signaling, 3129) was used in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (L41G3)
  • western blot; human
Cell Signaling Technology c-Met antibody (Cell Signaling, 3148) was used in western blot on human samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (D26)
  • immunohistochemistry - paraffin section; mouse
Cell Signaling Technology c-Met antibody (Cell Signaling, 3077) was used in immunohistochemistry - paraffin section on mouse samples . PLoS ONE (2014) ncbi
mouse monoclonal (25H2)
  • western blot; human
Cell Signaling Technology c-Met antibody (Cell Signaling Technology, 3127) was used in western blot on human samples . Mol Cell Biol (2014) ncbi
domestic rabbit monoclonal (D26)
  • western blot; human
Cell Signaling Technology c-Met antibody (Cell Signaling Technology, 3077) was used in western blot on human samples . Mol Cell Biol (2014) ncbi
domestic rabbit monoclonal (D1C2)
  • immunoprecipitation; human
  • western blot; human
Cell Signaling Technology c-Met antibody (Cell Signaling Technology, 8198) was used in immunoprecipitation on human samples and in western blot on human samples . Mol Cell Biol (2014) ncbi
domestic rabbit monoclonal (130H2)
  • immunohistochemistry; human; fig 1
In order to study the ability of Met inhibitors to reverse chemoresistance in small cell lung cancer and the role of epithelial-to-mesenchymal transition, Cell Signaling Technology c-Met antibody (Cell Signaling, 130H2) was used in immunohistochemistry on human samples (fig 1). Clin Cancer Res (2014) ncbi
Articles Reviewed
  1. Zhang X, Luo Y, Cen Y, Qiu X, Li J, Jie M, et al. MACC1 promotes pancreatic cancer metastasis by interacting with the EMT regulator SNAI1. Cell Death Dis. 2022;13:923 pubmed publisher
  2. Huang J, Wang X, Li B, Shen S, Wang R, Tao H, et al. L-5-hydroxytryptophan promotes antitumor immunity by inhibiting PD-L1 inducible expression. J Immunother Cancer. 2022;10: pubmed publisher
  3. Sun H, Zheng J, Xiao J, Yue J, Shi Z, Xuan Z, et al. TOPK/PBK is phosphorylated by ERK2 at serine 32, promotes tumorigenesis and is involved in sorafenib resistance in RCC. Cell Death Dis. 2022;13:450 pubmed publisher
  4. Benkhoucha M, Tran N, Breville G, Senoner I, Bradfield P, Papayannopoulou T, et al. CD4+c-Met+Itgα4+ T cell subset promotes murine neuroinflammation. J Neuroinflammation. 2022;19:103 pubmed publisher
  5. Kinkhabwala A, Herbel C, Pankratz J, Yushchenko D, R xfc berg S, Praveen P, et al. MACSima imaging cyclic staining (MICS) technology reveals combinatorial target pairs for CAR T cell treatment of solid tumors. Sci Rep. 2022;12:1911 pubmed publisher
  6. Li E, Huang X, Zhang G, Liang T. Combinational blockade of MET and PD-L1 improves pancreatic cancer immunotherapeutic efficacy. J Exp Clin Cancer Res. 2021;40:279 pubmed publisher
  7. Lee S, Jung J, Lee Y, Kim S, Kim J, Kim B, et al. Targeting HSF1 as a Therapeutic Strategy for Multiple Mechanisms of EGFR Inhibitor Resistance in EGFR Mutant Non-Small-Cell Lung Cancer. Cancers (Basel). 2021;13: pubmed publisher
  8. Low J, Du W, Gocha T, Oguz G, Zhang X, Chen M, et al. Molecular docking-aided identification of small molecule inhibitors targeting β-catenin-TCF4 interaction. iScience. 2021;24:102544 pubmed publisher
  9. Olsen R, Ireland A, Kastner D, Groves S, Spainhower K, Pozo K, et al. ASCL1 represses a SOX9+ neural crest stem-like state in small cell lung cancer. Genes Dev. 2021;35:847-869 pubmed publisher
  10. Li X, Lin P, Tao Y, Jiang X, Li T, Wang Y, et al. LECT 2 Antagonizes FOXM1 Signaling via Inhibiting MET to Retard PDAC Progression. Front Cell Dev Biol. 2021;9:661122 pubmed publisher
  11. Huang H, Hu J, Maryam A, Huang Q, Zhang Y, Ramakrishnan S, et al. Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling. Nat Commun. 2021;12:2242 pubmed publisher
  12. Nagamura Y, Miyazaki M, Nagano Y, Yuki M, Fukami K, Yanagihara K, et al. PLEKHA5 regulates the survival and peritoneal dissemination of diffuse-type gastric carcinoma cells with Met gene amplification. Oncogenesis. 2021;10:25 pubmed publisher
  13. Matsuzawa F, Kamachi H, Mizukami T, Einama T, Kawamata F, Fujii Y, et al. Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells. BMC Cancer. 2021;21:200 pubmed publisher
  14. Chen J, Xu D, Cao J, Zuo L, Han Z, Tian Y, et al. TRIM47 promotes malignant progression of renal cell carcinoma by degrading P53 through ubiquitination. Cancer Cell Int. 2021;21:129 pubmed publisher
  15. Kajiwara K, Yamano S, Aoki K, Okuzaki D, Matsumoto K, Okada M. CDCP1 promotes compensatory renal growth by integrating Src and Met signaling. Life Sci Alliance. 2021;4: pubmed publisher
  16. Delgado E, Erickson H, Tao J, Monga S, Duncan A, Anakk S. Scaffolding Protein IQGAP1 is Dispensable But Its Overexpression Promotes Hepatocellular Carcinoma via YAP1 Signaling. Mol Cell Biol. 2021;: pubmed publisher
  17. Isomura H, Taguchi A, Kajino T, Asai N, Nakatochi M, Kato S, et al. Conditional Ror1 knockout reveals crucial involvement in lung adenocarcinoma development and identifies novel HIF-1α regulator. Cancer Sci. 2021;: pubmed publisher
  18. Cai H, Yu Y, Ni X, Li C, Hu Y, Wang J, et al. LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis. Cell Death Dis. 2020;11:1032 pubmed publisher
  19. Benavente F, Piltti K, Hooshmand M, Nava A, Lakatos A, Feld B, et al. Novel C1q receptor-mediated signaling controls neural stem cell behavior and neurorepair. elife. 2020;9: pubmed publisher
  20. Qiu S, Van Rooijen J, Nienhuis H, van der Vegt B, Timmer Bosscha H, van Leeuwen Stok E, et al. High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer. Breast Cancer Res. 2020;22:30 pubmed publisher
  21. Mahameed M, Boukeileh S, Obiedat A, Darawshi O, Dipta P, Rimon A, et al. Pharmacological induction of selective endoplasmic reticulum retention as a strategy for cancer therapy. Nat Commun. 2020;11:1304 pubmed publisher
  22. Duplaquet L, Leroy C, Vinchent A, Paget S, Lefebvre J, Vanden Abeele F, et al. Control of cell death/survival balance by the MET dependence receptor. elife. 2020;9: pubmed publisher
  23. Meng X, Zhao Y, Han B, Zha C, Zhang Y, Li Z, et al. Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling pathways. Nat Commun. 2020;11:594 pubmed publisher
  24. Cheung E, DeNicola G, Nixon C, Blyth K, Labuschagne C, Tuveson D, et al. Dynamic ROS Control by TIGAR Regulates the Initiation and Progression of Pancreatic Cancer. Cancer Cell. 2020;37:168-182.e4 pubmed publisher
  25. Zhang X, Olsavszky V, Yin Y, Wang B, Engleitner T, Ollinger R, et al. Angiocrine Hepatocyte Growth Factor Signaling Controls Physiological Organ and Body Size and Dynamic Hepatocyte Proliferation to Prevent Liver Damage during Regeneration. Am J Pathol. 2020;190:358-371 pubmed publisher
  26. Lenting K, van den Heuvel C, van Ewijk A, Elmelik D, de Boer R, Tindall E, et al. Mapping actionable pathways and mutations in brain tumours using targeted RNA next generation sequencing. Acta Neuropathol Commun. 2019;7:185 pubmed publisher
  27. Xu M, Xu H, Lin Y, Sun X, Wang L, Fang Z, et al. LECT2, a Ligand for Tie1, Plays a Crucial Role in Liver Fibrogenesis. Cell. 2019;178:1478-1492.e20 pubmed publisher
  28. Matsumoto S, Yamamichi T, Shinzawa K, Kasahara Y, Nojima S, Kodama T, et al. GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGFβ signaling. Nat Commun. 2019;10:3882 pubmed publisher
  29. Jiang S, Zhang M, Zhang Y, Zhou W, Zhu T, Ruan Q, et al. WNT5B governs the phenotype of basal-like breast cancer by activating WNT signaling. Cell Commun Signal. 2019;17:109 pubmed publisher
  30. Li Q, Lai Q, He C, Fang Y, Yan Q, Zhang Y, et al. RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer. J Exp Clin Cancer Res. 2019;38:334 pubmed publisher
  31. Bi J, Ichu T, Zanca C, Yang H, Zhang W, Gu Y, et al. Oncogene Amplification in Growth Factor Signaling Pathways Renders Cancers Dependent on Membrane Lipid Remodeling. Cell Metab. 2019;30:525-538.e8 pubmed publisher
  32. Bando H, Pradipta A, Iwanaga S, Okamoto T, Okuzaki D, Tanaka S, et al. CXCR4 regulates Plasmodium development in mouse and human hepatocytes. J Exp Med. 2019;: pubmed publisher
  33. Singh R, Peng S, Viswanath P, Sambandam V, Shen L, Rao X, et al. Non-canonical cMet regulation by vimentin mediates Plk1 inhibitor-induced apoptosis. EMBO Mol Med. 2019;: pubmed publisher
  34. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  35. Chen M, Du Y, Sun L, Hsu J, Wang Y, Gao Y, et al. H2O2 induces nuclear transport of the receptor tyrosine kinase c-MET in breast cancer cells via a membrane-bound retrograde trafficking mechanism. J Biol Chem. 2019;294:8516-8528 pubmed publisher
  36. Kennedy S, Han J, Portman N, Nobis M, Hastings J, Murphy K, et al. Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer. Breast Cancer Res. 2019;21:43 pubmed publisher
  37. Huang X, Gan G, Wang X, Xu T, Xie W. The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance. Autophagy. 2019;15:1258-1279 pubmed publisher
  38. Martin V, Chiriaco C, Modica C, Acquadro A, Cortese M, Galimi F, et al. Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours. Br J Cancer. 2019;120:527-536 pubmed publisher
  39. Xie Y, Fan H, Lu W, Yang Q, Nurkesh A, Yeleussizov T, et al. Nuclear MET requires ARF and is inhibited by carbon nanodots through binding to phospho-tyrosine in prostate cancer. Oncogene. 2019;38:2967-2983 pubmed publisher
  40. Grohmann M, Wiede F, Dodd G, Gurzov E, Ooi G, Butt T, et al. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC. Cell. 2018;175:1289-1306.e20 pubmed publisher
  41. Bhalla M, Van Ngo H, Gyanwali G, Ireton K. The Host Scaffolding Protein Filamin A and the Exocyst Complex Control Exocytosis during InlB-Mediated Entry of Listeria monocytogenes. Infect Immun. 2019;87: pubmed publisher
  42. LI Y, Du L, Aldana Masangkay G, Wang X, Urak R, Forman S, et al. Regulation of miR-34b/c-targeted gene expression program by SUMOylation. Nucleic Acids Res. 2018;: pubmed publisher
  43. Fan P, Narzisi G, Jayaprakash A, Venturini E, Robine N, Smibert P, et al. YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics. Proc Natl Acad Sci U S A. 2018;115:E6030-E6038 pubmed publisher
  44. Ruess D, Heynen G, Ciecielski K, Ai J, Berninger A, Kabacaoglu D, et al. Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase. Nat Med. 2018;24:954-960 pubmed publisher
  45. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  46. Kelso T, Porter D, Amaral M, Shokhirev M, Benner C, Hargreaves D. Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers. elife. 2017;6: pubmed publisher
  47. Kamitakahara A, Wu H, Levitt P. Distinct projection targets define subpopulations of mouse brainstem vagal neurons that express the autism-associated MET receptor tyrosine kinase. J Comp Neurol. 2017;525:3787-3808 pubmed publisher
  48. Baumann C, Ullrich A, Torka R. GAS6-expressing and self-sustaining cancer cells in 3D spheroids activate the PDK-RSK-mTOR pathway for survival and drug resistance. Mol Oncol. 2017;11:1430-1447 pubmed publisher
  49. Laviolette L, Mermoud J, Calvo I, Olson N, Boukhali M, Steinlein O, et al. Negative regulation of EGFR signalling by the human folliculin tumour suppressor protein. Nat Commun. 2017;8:15866 pubmed publisher
  50. Chen X, Wu Q, Depeille P, Chen P, Thornton S, Kalirai H, et al. RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma. Cancer Cell. 2017;31:685-696.e6 pubmed publisher
  51. Lu X, Horner J, Paul E, Shang X, Troncoso P, Deng P, et al. Effective combinatorial immunotherapy for castration-resistant prostate cancer. Nature. 2017;543:728-732 pubmed publisher
  52. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  53. Deying W, Feng G, Shumei L, Hui Z, Ming L, Hongqing W. CAF-derived HGF promotes cell proliferation and drug resistance by up-regulating the c-Met/PI3K/Akt and GRP78 signalling in ovarian cancer cells. Biosci Rep. 2017;37: pubmed publisher
  54. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed publisher
  55. Duclos C, Champagne A, Carrier J, Saucier C, Lavoie C, Denault J. Caspase-mediated proteolysis of the sorting nexin 2 disrupts retromer assembly and potentiates Met/hepatocyte growth factor receptor signaling. Cell Death Discov. 2017;3:16100 pubmed publisher
  56. Nita I, Hostettler K, Tamo L, Medová M, Bombaci G, Zhong J, et al. Hepatocyte growth factor secreted by bone marrow stem cell reduce ER stress and improves repair in alveolar epithelial II cells. Sci Rep. 2017;7:41901 pubmed publisher
  57. . Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543:378-384 pubmed publisher
  58. Hill S, Nesser N, Johnson Camacho K, Jeffress M, Johnson A, Boniface C, et al. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling. Cell Syst. 2017;4:73-83.e10 pubmed publisher
  59. Vakana E, Pratt S, Blosser W, Dowless M, Simpson N, Yuan X, et al. LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer. Oncotarget. 2017;8:9251-9266 pubmed publisher
  60. Wymant J, Hiscox S, Westwell A, Urbé S, Clague M, Jones A. The Role of BCA2 in the Endocytic Trafficking of EGFR and Significance as a Prognostic Biomarker in Cancer. J Cancer. 2016;7:2388-2407 pubmed
  61. Leung E, Xue A, Wang Y, Rougerie P, Sharma V, Eddy R, et al. Blood vessel endothelium-directed tumor cell streaming in breast tumors requires the HGF/C-Met signaling pathway. Oncogene. 2017;36:2680-2692 pubmed publisher
  62. Grugan K, Dorn K, Jarantow S, Bushey B, Pardinas J, Laquerre S, et al. Fc-mediated activity of EGFR x c-Met bispecific antibody JNJ-61186372 enhanced killing of lung cancer cells. MAbs. 2017;9:114-126 pubmed publisher
  63. Adachi E, Sakai K, Nishiuchi T, Imamura R, Sato H, Matsumoto K. Different growth and metastatic phenotypes associated with a cell-intrinsic change of Met in metastatic melanoma. Oncotarget. 2016;7:70779-70793 pubmed publisher
  64. LAW M, Ferreira R, Davis B, Higgins P, Kim J, Castellano R, et al. CUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachment. Breast Cancer Res. 2016;18:80 pubmed publisher
  65. Qin Y, Roszik J, Chattopadhyay C, Hashimoto Y, Liu C, Cooper Z, et al. Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma. Mol Cancer Ther. 2016;15:2442-2454 pubmed
  66. Kemper K, Krijgsman O, Kong X, Cornelissen Steijger P, Shahrabi A, Weeber F, et al. BRAF(V600E) Kinase Domain Duplication Identified in Therapy-Refractory Melanoma Patient-Derived Xenografts. Cell Rep. 2016;16:263-277 pubmed publisher
  67. Huber M, Falkenberg N, Hauck S, Priller M, Braselmann H, Feuchtinger A, et al. Cyr61 and YB-1 are novel interacting partners of uPAR and elevate the malignancy of triple-negative breast cancer. Oncotarget. 2016;7:44062-44075 pubmed publisher
  68. Fox R, Lytle N, Jaquish D, Park F, Ito T, Bajaj J, et al. Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma. Nature. 2016;534:407-411 pubmed publisher
  69. Oh T, Wang S, Acharya B, Goode J, Graham J, Clarke C, et al. The Nuclear Receptor, ROR?, Regulates Pathways Necessary for Breast Cancer Metastasis. EBioMedicine. 2016;6:59-72 pubmed publisher
  70. Cozzo A, Sundaram S, Zattra O, Qin Y, Freemerman A, Essaid L, et al. cMET inhibitor crizotinib impairs angiogenesis and reduces tumor burden in the C3(1)-Tag model of basal-like breast cancer. Springerplus. 2016;5:348 pubmed publisher
  71. Huang M, Liu T, Ma P, Mitteer R, Zhang Z, Kim H, et al. c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma. J Clin Invest. 2016;126:1801-14 pubmed publisher
  72. Su K, Cao J, Tang Z, Dai S, He Y, Sampson S, et al. HSF1 critically attunes proteotoxic stress sensing by mTORC1 to combat stress and promote growth. Nat Cell Biol. 2016;18:527-39 pubmed publisher
  73. Krampitz G, George B, Willingham S, Volkmer J, Weiskopf K, Jahchan N, et al. Identification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors. Proc Natl Acad Sci U S A. 2016;113:4464-9 pubmed publisher
  74. Morena D, Maestro N, Bersani F, Forni P, Lingua M, Foglizzo V, et al. Hepatocyte Growth Factor-mediated satellite cells niche perturbation promotes development of distinct sarcoma subtypes. elife. 2016;5: pubmed publisher
  75. Zhang T, Boominathan R, Foulk B, Rao C, Kemeny G, Strickler J, et al. Development of a Novel c-MET-Based CTC Detection Platform. Mol Cancer Res. 2016;14:539-47 pubmed publisher
  76. De Herdt M, Willems S, van der Steen B, Noorlag R, Verhoef E, van Leenders G, et al. Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma. Oncotarget. 2016;7:13167-81 pubmed publisher
  77. Wang J, Goetsch L, Tucker L, Zhang Q, Gonzalez A, Vaidya K, et al. Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification. BMC Cancer. 2016;16:105 pubmed publisher
  78. Cui J, Xia T, Xie D, Gao Y, Jia Z, Wei D, et al. HGF/Met and FOXM1 form a positive feedback loop and render pancreatic cancer cells resistance to Met inhibition and aggressive phenotypes. Oncogene. 2016;35:4708-18 pubmed publisher
  79. Chu C, Bottaro D, Betenbaugh M, Shiloach J. Stable Ectopic Expression of ST6GALNAC5 Induces Autocrine MET Activation and Anchorage-Independence in MDCK Cells. PLoS ONE. 2016;11:e0148075 pubmed publisher
  80. Nassour J, Martien S, Martin N, Deruy E, Tomellini E, Malaquin N, et al. Defective DNA single-strand break repair is responsible for senescence and neoplastic escape of epithelial cells. Nat Commun. 2016;7:10399 pubmed publisher
  81. Yoshida T, Song L, Bai Y, Kinose F, Li J, Ohaegbulam K, et al. ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer. PLoS ONE. 2016;11:e0147344 pubmed publisher
  82. Du Y, Yamaguchi H, Wei Y, Hsu J, Wang H, Hsu Y, et al. Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors. Nat Med. 2016;22:194-201 pubmed publisher
  83. Yamaguchi T, Lu C, Ida L, Yanagisawa K, Usukura J, Cheng J, et al. ROR1 sustains caveolae and survival signalling as a scaffold of cavin-1 and caveolin-1. Nat Commun. 2016;7:10060 pubmed publisher
  84. Wang C, Che L, Hu J, Zhang S, Jiang L, Latte G, et al. Activated mutant forms of PIK3CA cooperate with RasV12 or c-Met to induce liver tumour formation in mice via AKT2/mTORC1 cascade. Liver Int. 2016;36:1176-86 pubmed publisher
  85. Fan S, Numata Y, Numata M. Endosomal Na+/H+ exchanger NHE5 influences MET recycling and cell migration. Mol Biol Cell. 2016;27:702-15 pubmed publisher
  86. Prince T, Kijima T, Tatokoro M, Lee S, Tsutsumi S, Yim K, et al. Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants. PLoS ONE. 2015;10:e0141786 pubmed publisher
  87. Liu F, Hon G, Villa G, Turner K, Ikegami S, Yang H, et al. EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling. Mol Cell. 2015;60:307-18 pubmed publisher
  88. Yokdang N, Hatakeyama J, Wald J, Simion C, Tellez J, Chang D, et al. LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells. Oncogene. 2016;35:2932-47 pubmed publisher
  89. Vennin C, Spruyt N, Dahmani F, Julien S, Bertucci F, Finetti P, et al. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b. Oncotarget. 2015;6:29209-23 pubmed publisher
  90. Reuther C, Heinzle V, Spampatti M, Vlotides G, de Toni E, Spöttl G, et al. Cabozantinib and Tivantinib, but Not INC280, Induce Antiproliferative and Antimigratory Effects in Human Neuroendocrine Tumor Cells in vitro: Evidence for 'Off-Target' Effects Not Mediated by c-Met Inhibition. Neuroendocrinology. 2016;103:383-401 pubmed publisher
  91. Chen L, Li C, Zhu Y. The HGF inhibitory peptide HGP-1 displays promising in vitro and in vivo efficacy for targeted cancer therapy. Oncotarget. 2015;6:30088-101 pubmed publisher
  92. Min H, Yun H, Lee J, Lee H, Cho J, Jang H, et al. Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer. Mol Cancer. 2015;14:113 pubmed publisher
  93. Zucha M, Wu A, Lee W, Wang L, Lin W, Yuan C, et al. Bruton's tyrosine kinase (Btk) inhibitor ibrutinib suppresses stem-like traits in ovarian cancer. Oncotarget. 2015;6:13255-68 pubmed
  94. Li Q, Li Q, Nuccio J, Liu C, Duan P, Wang R, et al. Metastasis initiating cells in primary prostate cancer tissues from transurethral resection of the prostate (TURP) predicts castration-resistant progression and survival of prostate cancer patients. Prostate. 2015;75:1312-21 pubmed publisher
  95. Finisguerra V, Di Conza G, Di Matteo M, Serneels J, Costa S, Thompson A, et al. MET is required for the recruitment of anti-tumoural neutrophils. Nature. 2015;522:349-53 pubmed publisher
  96. Chang J, Lehtinen M, Sive H. Zebrafish cerebrospinal fluid mediates cell survival through a retinoid signaling pathway. Dev Neurobiol. 2016;76:75-92 pubmed publisher
  97. Navis A, van Lith S, van Duijnhoven S, de Pooter M, Yetkin Arik B, Wesseling P, et al. Identification of a novel MET mutation in high-grade glioma resulting in an auto-active intracellular protein. Acta Neuropathol. 2015;130:131-44 pubmed publisher
  98. Kim Y, Jin D, Lee B, Cho E, Han J, Shim Y, et al. RARβ2 hypermethylation is associated with poor recurrence-free survival in never-smokers with adenocarcinoma of the lung. Clin Epigenetics. 2015;7:32 pubmed publisher
  99. Le A, Huang Y, Pingle S, Kesari S, Wang H, Yong R, et al. Plexin-B2 promotes invasive growth of malignant glioma. Oncotarget. 2015;6:7293-304 pubmed
  100. Kobayashi K, Sakurai K, Hiramatsu H, Inada K, Shiogama K, Nakamura S, et al. The miR-199a/Brm/EGR1 axis is a determinant of anchorage-independent growth in epithelial tumor cell lines. Sci Rep. 2015;5:8428 pubmed publisher
  101. Greenall S, Donoghue J, van Sinderen M, Dubljevic V, Budiman S, Devlin M, et al. EGFRvIII-mediated transactivation of receptor tyrosine kinases in glioma: mechanism and therapeutic implications. Oncogene. 2015;34:5277-87 pubmed publisher
  102. Papadakis A, Sun C, Knijnenburg T, Xue Y, Grernrum W, Hölzel M, et al. SMARCE1 suppresses EGFR expression and controls responses to MET and ALK inhibitors in lung cancer. Cell Res. 2015;25:445-58 pubmed publisher
  103. Santhana Kumar K, Tripolitsioti D, Ma M, Grählert J, Egli K, Fiaschetti G, et al. The Ser/Thr kinase MAP4K4 drives c-Met-induced motility and invasiveness in a cell-based model of SHH medulloblastoma. Springerplus. 2015;4:19 pubmed publisher
  104. Mahadevan D, Theiss N, Morales C, Stejskal A, Cooke L, Zhu M, et al. Novel receptor tyrosine kinase targeted combination therapies for imatinib-resistant gastrointestinal stromal tumors (GIST). Oncotarget. 2015;6:1954-66 pubmed
  105. Matte I, Lane D, Laplante C, Garde Granger P, Rancourt C, Piché A. Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms. Int J Cancer. 2015;137:289-98 pubmed publisher
  106. Heynen G, Fonfara A, Bernards R. Resistance to targeted cancer drugs through hepatocyte growth factor signaling. Cell Cycle. 2014;13:3808-17 pubmed publisher
  107. Kim H, Xu H, Yao Q, Li W, Huang Q, Outeda P, et al. Ciliary membrane proteins traffic through the Golgi via a Rabep1/GGA1/Arl3-dependent mechanism. Nat Commun. 2014;5:5482 pubmed publisher
  108. Ciamporcero E, Miles K, Adelaiye R, Ramakrishnan S, Shen L, Ku S, et al. Combination strategy targeting VEGF and HGF/c-met in human renal cell carcinoma models. Mol Cancer Ther. 2015;14:101-10 pubmed publisher
  109. Korhan P, Erdal E, Kandemiş E, Cokakli M, Nart D, Yilmaz F, et al. Reciprocal activating crosstalk between c-Met and caveolin 1 promotes invasive phenotype in hepatocellular carcinoma. PLoS ONE. 2014;9:e105278 pubmed publisher
  110. Gargalionis A, Korkolopoulou P, Farmaki E, Piperi C, Dalagiorgou G, Adamopoulos C, et al. Polycystin-1 and polycystin-2 are involved in the acquisition of aggressive phenotypes in colorectal cancer. Int J Cancer. 2015;136:1515-27 pubmed publisher
  111. Xie Y, Lu W, Liu S, Yang Q, Carver B, Li E, et al. Crosstalk between nuclear MET and SOX9/?-catenin correlates with castration-resistant prostate cancer. Mol Endocrinol. 2014;28:1629-39 pubmed publisher
  112. Korhan P, Erdal E, Atabey N. MiR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met. Biochem Biophys Res Commun. 2014;450:1304-12 pubmed publisher
  113. Etnyre D, Stone A, Fong J, Jacobs R, Uppada S, Botting G, et al. Targeting c-Met in melanoma: mechanism of resistance and efficacy of novel combinatorial inhibitor therapy. Cancer Biol Ther. 2014;15:1129-41 pubmed publisher
  114. Yi X, Li X, Zhou Y, Ren S, Wan W, Feng G, et al. Hepatocyte growth factor regulates the TGF-?1-induced proliferation, differentiation and secretory function of cardiac fibroblasts. Int J Mol Med. 2014;34:381-90 pubmed publisher
  115. Elliott V, Rychahou P, Zaytseva Y, Evers B. Activation of c-Met and upregulation of CD44 expression are associated with the metastatic phenotype in the colorectal cancer liver metastasis model. PLoS ONE. 2014;9:e97432 pubmed publisher
  116. Cen B, Xiong Y, Song J, Mahajan S, DuPont R, McEachern K, et al. The Pim-1 protein kinase is an important regulator of MET receptor tyrosine kinase levels and signaling. Mol Cell Biol. 2014;34:2517-32 pubmed publisher
  117. Terwisscha van Scheltinga A, Lub de Hooge M, Hinner M, Verheijen R, Allersdorfer A, Hülsmeyer M, et al. In vivo visualization of MET tumor expression and anticalin biodistribution with the MET-specific anticalin 89Zr-PRS-110 PET tracer. J Nucl Med. 2014;55:665-71 pubmed publisher
  118. Cañadas I, Rojo F, Taus A, Arpi O, Arumi Uria M, Pijuan L, et al. Targeting epithelial-to-mesenchymal transition with Met inhibitors reverts chemoresistance in small cell lung cancer. Clin Cancer Res. 2014;20:938-50 pubmed publisher
  119. Tsai C, Yang C, Wang J, Tsai Y, Tseng L, King K, et al. Timosaponin AIII Suppresses Hepatocyte Growth Factor-Induced Invasive Activity through Sustained ERK Activation in Breast Cancer MDA-MB-231 Cells. Evid Based Complement Alternat Med. 2013;2013:421051 pubmed publisher
  120. Lee S, Seol H, Lee H, Kang W, Kang B, Jin J, et al. Gene silencing of c-Met leads to brain metastasis inhibitory effects. Clin Exp Metastasis. 2013;30:845-54 pubmed publisher
  121. Baek H, Noh Y, Lee J, Yeon S, Jeong J, Kwon H. Autonomous isolation, long-term culture and differentiation potential of adult salivary gland-derived stem/progenitor cells. J Tissue Eng Regen Med. 2014;8:717-27 pubmed publisher
  122. Straussman R, Morikawa T, Shee K, Barzily Rokni M, Qian Z, Du J, et al. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature. 2012;487:500-4 pubmed publisher
  123. Tretiakova M, Salama A, Karrison T, Ferguson M, Husain A, Vokes E, et al. MET and phosphorylated MET as potential biomarkers in lung cancer. J Environ Pathol Toxicol Oncol. 2011;30:341-54 pubmed
  124. Jung Y, Joo K, Seong D, Choi Y, Kong D, Kim Y, et al. Identification of prognostic biomarkers for glioblastomas using protein expression profiling. Int J Oncol. 2012;40:1122-32 pubmed publisher
  125. Seiwert T, Jagadeeswaran R, Faoro L, Janamanchi V, Nallasura V, El Dinali M, et al. The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma. Cancer Res. 2009;69:3021-31 pubmed publisher
  126. Kong D, Song S, Kim D, Joo K, Yoo J, Koh J, et al. Prognostic significance of c-Met expression in glioblastomas. Cancer. 2009;115:140-8 pubmed publisher